<DOC>
	<DOCNO>NCT00198315</DOCNO>
	<brief_summary>The purpose study evaluate Medpulser electroporation ( EPT ) bleomycin regard local tumor recurrence , disease-free survival , overall survival rate versus surgery recurrent secondary primary squamous cell carcinoma ( SCC ) anterior oral cavity , soft palate , tonsil .</brief_summary>
	<brief_title>Medpulser Electroporation With Bleomycin Study Treat Anterior Head Neck Squamous Cell Carcinoma</brief_title>
	<detailed_description>Recurrent tumor head neck squamous cell carcinoma usually poor prognosis . In patient suitable salvage surgery recurrent disease , success rate local control report 40-50 % . The surgical treatment H &amp; N SCC frequently result significant loss organ function ( e.g. , inability swallow , speak , etc . ) and/or permanent disfigurement . There compel unmet medical need local therapy destroy tumor preserve function status appearance patient primary , recurrent , metastatic H &amp; N SCC . Comparison : To compare function status 4 month treatment bleomycin-EPT surgery patient locally recurrent second primary SCC anterior oral cavity , soft palate , tonsil fail primary curative therapy surgical resection see option disease control .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>1 . The presence SCC anterior oral cavity , soft palate tonsil must confirm histological examination tissue sample ( e.g. , biopsy ) obtain within 1 month patient receive study treatment . 2 . Recurrent second primary disease patient surgical resection see option disease control . 3 . The length long diameter study lesion must &lt; 5 cm calculate treatment volume must &lt; 60.0 cm3 ( tumor volume plus 0.5 cm margin around tumor ) study lesion [ treatment volume = 0.5 ( A+1 ) ( B+1 ) 2 A = length long diameter ( cm ) , B = next long diameter perpendicular `` A '' ( cm ) ] . 4 . Tumor burden must completely encompass surgery bleomycinEPT . 5 . Age : 18 year old . 6 . Men woman childbearing potential must use physician approve contraceptive method 7 day follow bleomycinEPT . 7 . Hematopoietic status : Absolute neutrophil count ( ANC ) &gt; 1000/uL Platelets &gt; 75,000/mm3 Prothrombin time : international normalized ratio ( PT : INR ) ? 1.5 ( correctable vitamin K injection ) 8 . Blood chemistry status : Transaminases &lt; 3 time upper limit normal Total bilirubin &lt; 2.5 mg/dL Creatinine &lt; 2.5 mg/dL 9 . A write Informed Consent form must sign prior patient receive study procedure treatment . 1 . Patients tumor suspect involve 50 % great encasement blood vessel measure magnetic resonance imaging ( MRI ) compute tomography ( CT ) scan . 2 . Patients tumor bone invasion . 3 . Patients metallic implant treatment field . 4 . Patients hypersensitivity bleomycin . 5 . Patients receive exceed total lifetime dose bleomycin great 400 unit . 6 . Patients deem unsuitable general anesthesia . 7 . Patients significant history emphysema pulmonary fibrosis . 8 . Patients indwell cardiac pacemaker tolerate period pacemaker turn . 9 . Patients history uncontrolled cardiac arrhythmia . 10 . Women pregnant , nursing . Women childbearing potential must negative betahuman chorionic gonadotropin ( betaHCG ) test within 7 day study treatment . 11 . Radiation therapy treatment area within 8 week study treatment . 12 . Chemotherapy cancer therapy ( e.g. , surgery , cryotherapy , etc . ) treatment area within 4 week study treatment . 13 . Patients participate clinical study investigational drug device within 4 week prior study treatment . 14 . Patients previously randomize study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Squamous Cell Carcinoma</keyword>
	<keyword>Carcinoma</keyword>
	<keyword>Head Neck Cancer</keyword>
	<keyword>Oral</keyword>
	<keyword>Soft Palate</keyword>
	<keyword>Cancer</keyword>
	<keyword>Medpulser</keyword>
	<keyword>Electroporation</keyword>
	<keyword>Local recurrent second primary squamous cell carcinoma anterior oral cavity , soft palate , tonsil</keyword>
</DOC>